Literature DB >> 19347772

Prognostic factors for invasive aspergillosis in patients with haematological malignancies.

Stefan Reuter1, Winfried Kern, Claudia Zenz, Peter Kern.   

Abstract

Reliable data defining risk factors for invasive aspergillosis (IA) in haematological patients are limited. Analysis of factors influencing IA-associated death is especially valuable in the light of recent progress in managing IA. Between 1997 and 2005 we evaluated factors influencing IA-attributable mortality. For univariate analyses we used Wilcoxon and log-rank test, and for multivariate analysis a Cox model of logistic backward regression was applied. Attributable mortality was 41% after 1 y. 50% of attributable deaths occurred within 6 weeks after IA diagnosis. Various parameters significantly correlated with death after IA: 1) uncontrolled malignancy (p =0.007); 2) extrapulmonary disease (p =0.0003); 3) stable disease, mixed response or progressive disease at first radiological evaluation (p =0.004); 4) proven IA (p =0.02); 5) IA > 110 d after PBSCT (p =0.0112). Prolonged duration of neutropenia was associated with increased mortality (p =0.0001). We observed a trend towards improved survival of IA during recent y (2003-2005). In a multivariate analysis, factors independently associated with attributable mortality included y of first diagnosis (p =0.0492), extrapulmonary IA (p =0.0353) and duration of neutropenia (p =0.0088). In conclusion, the identified risk factors may serve for the definition of high-risk situations. In these settings, increased efforts of prevention, early diagnosis and aggressive treatment of IA are warranted in order to improve survival.

Entities:  

Mesh:

Year:  2009        PMID: 19347772     DOI: 10.1080/00365540902856529

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  5 in total

1.  Assessing responses to treatment of opportunistic mycoses and salvage strategies.

Authors:  Baldeep Wirk; John R Wingard
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

2.  Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study.

Authors:  Livio Pagano; Morena Caira; Anna Candoni; Massimo Offidani; Bruno Martino; Giorgina Specchia; Domenico Pastore; Marta Stanzani; Chiara Cattaneo; Rosa Fanci; Cecilia Caramatti; Fausto Rossini; Mario Luppi; Leonardo Potenza; Felicetto Ferrara; Maria Enza Mitra; Rafaela Maria Fadda; Rosangela Invernizzi; Teresa Aloisi; Marco Picardi; Alessandro Bonini; Adriana Vacca; Anna Chierichini; Lorella Melillo; Chiara de Waure; Luana Fianchi; Marta Riva; Giuseppe Leone; Franco Aversa; Annamaria Nosari
Journal:  Haematologica       Date:  2009-10-22       Impact factor: 9.941

3.  Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.

Authors:  Simone Aranha Nouér; Marcio Nucci; Naveen Sanath Kumar; Monica Grazziutti; Alejandro Restrepo; Elias Anaissie
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

4.  Neutropenia and invasive fungal infection in patients with hematological malignancies treated with chemotherapy: a multicenter, prospective, non-interventional study in China.

Authors:  Yonghua Li; Wenning Xu; Zujun Jiang; Yang Gao; Yan Pang; Li Li; Ling OuYang; Leqing Zhang; Zenghui Liu; Yang Wang; Yang Xiao; Xiaojun Huang
Journal:  Tumour Biol       Date:  2014-03-25

5.  Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study.

Authors:  Chiara Cattaneo; Alessandro Busca; Doriana Gramegna; Francesca Farina; Anna Candoni; Monica Piedimonte; Nicola Fracchiolla; Chiara Pagani; Maria Ilaria Del Principe; Maria Chiara Tisi; Massimo Offidani; Rosa Fanci; Stelvio Ballanti; Angelica Spolzino; Marianna Criscuolo; Francesco Marchesi; Gianpaolo Nadali; Mario Delia; Marco Picardi; Margherita Sciumé; Valentina Mancini; Attilio Olivieri; Mario Tumbarello; Giuseppe Rossi; Livio Pagano
Journal:  Hemasphere       Date:  2019-11-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.